---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-029261"
form_type: "8-K"
ticker: "BJDX"
cik: "0001704287"
company_name: "Bluejay Diagnostics, Inc."
filed_at: "2026-03-17T23:59:59+00:00"
generated_at: "2026-05-15T10:32:11.845347+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Bluejay Diagnostics raises $125,000 in private placement to insiders at $2.00/share

## Summary
- Issued 62,500 shares of common stock at $2.00 per share to five insiders, including CEO Neil Dey and Chair Donald Chase.
- Gross proceeds of $125,000; sale closed on March 17, 2026, under Section 4(a)(2)/Reg D exemption.
- No registration rights were granted; shares are restricted securities.
- Proceeds likely used for general working capital; no other material terms disclosed.
- All purchasers represented as accredited investors.

## SEC filing metadata
- accession: 0001213900-26-029261
- form_type: 8-K
- ticker: BJDX
- cik: 0001704287
- company_name: Bluejay Diagnostics, Inc.
- filed_at: 2026-03-17T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1704287/000121390026029261/0001213900-26-029261-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1704287/000121390026029261/ea0282221-8k_bluejay.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-029261
- JSON: https://secwatch.observer/filing/0001213900-26-029261.json
- Plain text: https://secwatch.observer/filing/0001213900-26-029261.txt

## Key facts
- Material Agreements
  Bluejay Diagnostics, Inc. entered into Agreement with the purchasers named therein valued at $125,000 (effective 2024-03-14).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: the purchasers named therein
  - Value: $125,000
  - Effective: 2024-03-14
  source text: On March 14, 2024, Bluejay Diagnostics, Inc. (the “Company”) entered into a securities purchase agreement (the “Agreement”)
  evidence_url: https://www.sec.gov/Archives/edgar/data/1704287/000121390026029261/0001213900-26-029261-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.